The Efficacy of Different Chemotherapy Regimens for Advanced Biliary Tract Cancer: A Systematic Review and Network Meta-Analysis

Background: Although gemcitabine plus cisplatin (GP) is considered as standard chemotherapy for patients with advanced biliary tract cancer (BTC), the optimal regimen remains unknown. Methods: Using Network meta-analysis (NMA), a systematic review was conducted to find the most effective chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Zhou, Yaoyao, Hong, Yonglan, He, Meizhi, Wei, Shuyi, Yang, Chen, Zheng, Dayong, Liu, Feiye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549535/
https://www.ncbi.nlm.nih.gov/pubmed/31192137
http://dx.doi.org/10.3389/fonc.2019.00441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549535/
https://www.ncbi.nlm.nih.gov/pubmed/31192137
http://dx.doi.org/10.3389/fonc.2019.00441

Ejemplares similares